Fidelity Investments’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-826,758
| Closed | -$2.35M | – | 5713 |
|
|
2023
Q3 | $2.35M | Sell |
826,758
-1,109
| -0.1% | -$3.15K | ﹤0.01% | 2247 |
|
|
2023
Q2 | $2.15M | Sell |
827,867
-1,424,464
| -63% | -$3.7M | ﹤0.01% | 2295 |
|
|
2023
Q1 | $4.1M | Sell |
2,252,331
-656,045
| -23% | -$1.19M | ﹤0.01% | 2151 |
|
|
2022
Q4 | $4.8M | Sell |
2,908,376
-577,682
| -17% | -$953K | ﹤0.01% | 2140 |
|
|
2022
Q3 | $6.69M | Sell |
3,486,058
-386,231
| -10% | -$742K | ﹤0.01% | 2069 |
|
|
2022
Q2 | $11.6M | Sell |
3,872,289
-628,944
| -14% | -$1.88M | ﹤0.01% | 1899 |
|
|
2022
Q1 | $17M | Buy |
4,501,233
+452,240
| +11% | +$1.7M | ﹤0.01% | 1857 |
|
|
2021
Q4 | $46M | Sell |
4,048,993
-236,666
| -6% | -$2.69M | ﹤0.01% | 1456 |
|
|
2021
Q3 | $75.2M | Buy |
4,285,659
+3,225,453
| +304% | +$56.6M | 0.01% | 1236 |
|
|
2021
Q2 | $22.7M | Buy |
+1,060,206
| New | +$22.7M | ﹤0.01% | 1801 |
|